PSEN1 and Alzheimer disease: In vitro experiments with microglial cells exposed to Aβ oligomers, to model an AD environment, and treated with rAIBP, to model AIBP gain-of-function, produced results consisted with secreted AIBP loss-of-function in Apoa1bp−/− APP/PS1 brain.